期刊文献+

白介素18/白介素10比值与冠心病患者PCI后冠脉事件的关系 被引量:3

Relationship Between Interleukin-18/interleukin-10 Ratio and Coronary Events in Coronary Heart Disease Patients after PCI
下载PDF
导出
摘要 【目的】探索白介素18(IL-18)、白介素10(IL-10)与经皮冠脉内介入治疗(PCI)后冠脉事件(CE)发生的相关性,为预防PCI后CE的发生提供新思路。【方法】本研究纳入105例行PCI术的冠心病(CHD)患者,男性74例,女性31例,平均年龄(64.80±9.62)岁,根据随访结果把患者分为CE组和非CE组,采用酶联免疫吸附法分别测定两组患者血浆IL-18、IL-10,采用独立样本t检验分析两独立样本的均数差异,Logistic回归强迫引入法分析多个自变量与一个变量之间的线性数量关系。【结果】CE组患者PCI前血浆IL-18与IL-18/IL-10比值显著高于非CE组(P均〈0.01),CE组患者PCI前血浆IL-10显著低于非CE组(P〈0.01)。CHD患者血浆IL-18/IL-10比值、糖尿病、高血压、高脂血症分别使CHD患者PCI后CE的优势比(OR)值增加4.28倍、8.23倍、7.82倍、8.85倍(P均〈0.05)。【结论】除传统的CHD危险因素糖尿病、高血压、高脂血症外,CHD患者血浆IL-18/IL-10比值增大也增加CHD患者PCI后CE发生的风险。 [Objective]To investigate the relationship between interleukin-18 (IL-18), interleukin-10(IL- 10) and coronary events(CE) in coronary heart disease patients(CHD) after percutaneous coronary interven tion(PCI), and provide new ideas for prevention of CE after PCI. [Methods] A total of 105 CHD patients who had been treated by PCI, including 74 men and 31 women, were enrolled in this study. Their average age was (64.80 ± 9.62) years old. The patients were divided into CE group and non-CE group according to the results of the follow up. The plasma IL-18 and IL-10 levels in the patients were measured by enzyme linked immunosorbent assay, t-test was used to analyze the age distinction between two independent samples. Logistic regression was employed to analyze the linear relationship between multiple variables and one variable. [Results] Plasma IL-18 and IL-18/IL-10 ratio in the CE group were higher than those in non-CE group( P 〈0. 01). Plasma IL- 10 in the CE group was lower than that in non-CE group ( P 〈0.01). Logistic regression analysis showed that IL-18/IL-10 ratio, diabetes, byperlipidemia and hypertension increased the relative risk of CE in CHD patients'after PCI by 4.28, 8.23, 7.82 and 8.85 times, respectively( P 〈0.05). [Conclusion]Except for traditional CHD risk factors such as diabetes and hyperlipidemia, IL-18/IL-10 ratio can also increase the risk of CE in CHD patients after PCI.
出处 《医学临床研究》 CAS 2009年第10期1849-1852,共4页 Journal of Clinical Research
关键词 冠状动脉疾病 白细胞介素18 白细胞介素10 血管成形术 经腔 经皮冠状动脉 coronary disease interleukin-18 interleukin-10 angioplasty,transluminal, percutane ous coronary
  • 相关文献

参考文献10

  • 1Hernesniemi JA, Karhunen PJ, Rontu R, el al . Interleukin 18 promoter polymorphism associates with the occurrence of sudden cardiac death among caucasian males: the helsinki sudden death study[J]. Atherosclerosis , 2008, 196(2):643-649.
  • 2李巧汶,邱健,马骏,洪长江,阮云军,向定成,顾晓龙.冠心病患者血浆白介素18、白介素10的变化及其临床意义[J].医学临床研究,2008,25(1):16-18. 被引量:11
  • 3Li JM, Eslami MH, Rohrer MJ, et al . Interleukin 18 binding protein (IL18 -BP) inhibits neointimal hyperplasia after balloon injury in an atheroselerotie rabbit model[J]. J Vasc Surg , 2008, 47(5) :1048-1057.
  • 4Ikata J,Wakatsuki T,Oishi Y, et al . Leukocyte counts and concentration of soluble adhesion molecules as predictors of coronary Atherosclerosis[J]. Coron Artery Dis , 2000, 11(6) : 445.
  • 5Summary of second report of the national cholesterol education program (NCEP) expert panelon detection, evaluation, and treatment of high blood cholesterol in adults( adult treatment panel)[J].JAMA , 1993, 269(23): 30152-3023.
  • 6刘文卫,刘永胜,江华,朱锐,汤永谦,李彬,叶剑文,李素珍.冠心病合并2型糖尿病患者血清白介素-18水平检测[J].中国医师杂志,2007,9(6):834-835. 被引量:2
  • 7Thompson SR, McCaskie PA, Beilby JP, et al . IIA8 haplotypes are associated with serum IL-18 concentrations in a populationbased study and a cohort of individ uals with premature coronary heart disease[J]. Clln Chem , 2007, 53 (12): 2078-2085.
  • 8De Nooijer R, von der Thusen J H C, Verkleij CJ, et al . Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein E2deficient mice[J]. Arterioscler Thromb Vasc Biol, 2004, 24 (12): 2313-2319.
  • 9Chalikias GK. Interleukin- 18/interleukin 10 ratio is an independent predictor of recurrent coronary events during a 1 year follow-up in patients with acute coronary syndrome[J]. Int J Cardiol ,2007, 117(3) :333-339.
  • 10Chandrasekar B, Mummidi S, Valente AJ, et al . The proatherogenic cytokine interleukln-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin- 1 receptor-associated kinase, tumor necrosis factor receptor- associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling[J]. J Biol Chem ,2005, 280(28):26263-26277.

二级参考文献12

  • 1刘永胜,沈青山,朱锐,付度关,汤永谦,陶红,李素珍,叶剑文.氟伐他汀对不稳定型心绞痛患者CRP、TNF-α和cTnI的影响[J].国外医学(心血管疾病分册),2005,32(5):307-308. 被引量:8
  • 2洪梅,魏文宁,胡豫,杨锐,杨焰.Plasma Levels of the Anti-inflammatory Cytokine IL-10 and Inflammatory Cytokine IL-6 in Patients with Unstable Angina[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2005,25(6):639-641. 被引量:5
  • 3Gerdes N,Sukhova GK, Libby P, et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages : implications for atherogenesis. J Exp Med, 2002,195 (2) :245-257.
  • 4Blankenberg S,Tiret L,Bickel C,et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation, 2002,106( 1 ) :24-30.
  • 5Aso Y, Okumura K,Takebayashi K, et al. Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabetes Care,2003,26 (9) :2622-2627.
  • 6Kouroedov A, Eto M, Joeh H, et al. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation,2004,110 ( 1 ) :91-96.
  • 7Moriwaki Y, Yamamoto T, Shibutani Y, et al. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism, 2003,52(5 ) :605-608.
  • 8Marfella R,Esposito K,Siniscalchi M,et al. Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care,2004,27 (1) :47-52.
  • 9Gu K, Cowie CC, Harris MI, et al. Diabetes and decIine in heart disease mortality in US adults. JAMA, 1999 : 1291-1297.
  • 10Luc G, Bard JM, Juhan-Vaque I, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease The PRIME study. Arterioscler Thromb Vasc Biol,2003,23 ( 7 ) : 1255-1261.

共引文献11

同被引文献28

  • 1周忠民,赵重学.高血压的中医病机探讨[J].陕西中医,2008,29(2):193-195. 被引量:23
  • 2范金茹,吴华堂,戴小良,王行宽.滋阴平肝法降血压及逆转左室肥厚的实验研究[J].中国中医急症,2006,15(1):72-73. 被引量:5
  • 3戴小良,王行宽,范金茹,史锋,左艳,李水晴.滋生青阳片降压及逆转高血压左室肥厚的临床研究[J].中国中医急症,2006,15(11):1202-1203. 被引量:4
  • 4戴小良,范金茹,王行宽,李水晴,史锋.滋生青阳片改善高血压左室肥厚中医证候及降压的临床研究[J].中成药,2007,29(3):329-333. 被引量:7
  • 5Lakoski SG, Liu Y, Brosnihan KB, et al. Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis ( ERA ) study. Atherosclerosis, 2008,197 : 443- 447.
  • 6Inoue T, Node K. Molecular basis ofrestenosis and novel issues of drug-elutingstents. CireJ, 2009,73:615-621.
  • 7Fournier JA, Delgado-Pecellln C, Cayuela A, et al. The highsensitivity C reactive protein level one month after bare-metal coronary stenting may predict late adverse events. Rev Esp Cardiol, 2008,61 : 313-316.
  • 8Martinez-Eseibano JA, Moya-Quiles MR, Muro M, et al. Interleukin 10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients. Melanoma Res, 2002, 5: 465-469.
  • 9Koch W,Tiroch K,von-Beckerath N,et al. Tumor necrosis factor-alpha,lymphotoxin-alpha, and interleukin-10 gene polymorphisrns and restenosis after coronary artery stenting. Cytokine, 2003,24 : 161-171.
  • 10Monraats PS, Kurreeman FAS, Pons D, et al. Interleukin 10: a new risk marker for the development of restenosis after pereutaneous coronary intervention. Genes Immun, 2007,8: 44- 50.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部